316 related articles for article (PubMed ID: 1341991)
1. Management of psychotropic-induced hyperprolactinemia.
Marken PA; Haykal RF; Fisher JN
Clin Pharm; 1992 Oct; 11(10):851-6. PubMed ID: 1341991
[TBL] [Abstract][Full Text] [Related]
2. Hyperprolactinemia associated with psychotropics--a review.
Madhusoodanan S; Parida S; Jimenez C
Hum Psychopharmacol; 2010; 25(4):281-97. PubMed ID: 20521318
[TBL] [Abstract][Full Text] [Related]
3. [Antipsychotic-drug-induced hyperprolactinemia: physiopathology, clinical features and guidance].
Besnard I; Auclair V; Callery G; Gabriel-Bordenave C; Roberge C
Encephale; 2014 Feb; 40(1):86-94. PubMed ID: 23928066
[TBL] [Abstract][Full Text] [Related]
4. Switch to quetiapine in antipsychotic agent-related hyperprolactinemia.
Keller R; Mongini F
Neurol Sci; 2002 Dec; 23(5):233-5. PubMed ID: 12522680
[TBL] [Abstract][Full Text] [Related]
5. A randomized, crossover comparison of herbal medicine and bromocriptine against risperidone-induced hyperprolactinemia in patients with schizophrenia.
Yuan HN; Wang CY; Sze CW; Tong Y; Tan QR; Feng XJ; Liu RM; Zhang JZ; Zhang YB; Zhang ZJ
J Clin Psychopharmacol; 2008 Jun; 28(3):264-370. PubMed ID: 18480682
[TBL] [Abstract][Full Text] [Related]
6. Antipsychotic-induced hyperprolactinemia.
Bostwick JR; Guthrie SK; Ellingrod VL
Pharmacotherapy; 2009 Jan; 29(1):64-73. PubMed ID: 19113797
[TBL] [Abstract][Full Text] [Related]
7. Medication-induced hyperprolactinemia.
Molitch ME
Mayo Clin Proc; 2005 Aug; 80(8):1050-7. PubMed ID: 16092584
[TBL] [Abstract][Full Text] [Related]
8. Risperidone-induced symptomatic hyperprolactinaemia in adolescents.
Holzer L; Eap CB
J Clin Psychopharmacol; 2006 Apr; 26(2):167-71. PubMed ID: 16633146
[TBL] [Abstract][Full Text] [Related]
9. [The assessment of the mental state of patients during simultaneous treatment with psychotropic drugs, antipsychotics included, and bromocriptine].
Barszcz Z; Mucha S; Rabe-Jabłońska J
Psychiatr Pol; 2008; 42(4):595-607. PubMed ID: 19189603
[TBL] [Abstract][Full Text] [Related]
10. Antipsychotic-induced hyperprolactinemia and sexual dysfunction.
Compton MT; Miller AH
Psychopharmacol Bull; 2002; 36(1):143-64. PubMed ID: 12397853
[TBL] [Abstract][Full Text] [Related]
11. Neuroleptic-associated hyperprolactinemia. Can it be treated with bromocriptine?
Smith S
J Reprod Med; 1992 Aug; 37(8):737-40. PubMed ID: 1359137
[TBL] [Abstract][Full Text] [Related]
12. [Endocrinologic adverse effects of psychotropic drugs].
Elenitza IM
Vertex; 2005; 16(59):43-8. PubMed ID: 15785788
[TBL] [Abstract][Full Text] [Related]
13. Psychotropic-induced hyperprolactinemia: a clinical review.
Ajmal A; Joffe H; Nachtigall LB
Psychosomatics; 2014; 55(1):29-36. PubMed ID: 24140188
[TBL] [Abstract][Full Text] [Related]
14. Amantadine in the treatment of neuroendocrine side effects of neuroleptics.
Correa N; Opler LA; Kay SR; Birmaher B
J Clin Psychopharmacol; 1987 Apr; 7(2):91-5. PubMed ID: 2884239
[TBL] [Abstract][Full Text] [Related]
15. Clinical implications of antipsychotic-induced hyperprolactinemia in patients with schizophrenia spectrum or bipolar spectrum disorders: recent developments and current perspectives.
Byerly M; Suppes T; Tran QV; Baker RA
J Clin Psychopharmacol; 2007 Dec; 27(6):639-61. PubMed ID: 18004132
[TBL] [Abstract][Full Text] [Related]
16. Antipsychotic-induced hyperprolactinemia: a cross-sectional survey.
Johnsen E; Kroken RA; Abaza M; Olberg H; Jørgensen HA
J Clin Psychopharmacol; 2008 Dec; 28(6):686-90. PubMed ID: 19011438
[TBL] [Abstract][Full Text] [Related]
17. Serial plasma prolactin levels in neuroleptic-induced galactorrhea: a case report.
Gioia P; Asnis G
J Clin Psychiatry; 1988 Jan; 49(1):29-31. PubMed ID: 2891689
[TBL] [Abstract][Full Text] [Related]
18. Switching female schizophrenic patients to quetiapine from conventional antipsychotic drugs: effects on hyperprolactinemia.
Nakajima M; Terao T; Iwata N; Nakamura J
Pharmacopsychiatry; 2005 Jan; 38(1):17-9. PubMed ID: 15706461
[TBL] [Abstract][Full Text] [Related]
19. Low-dose risperidone augmentation of antidepressants or anxiolytics is associated with hyperprolactinemia.
Kopecek M; Bares M; Horacek J; Mohr P
Neuro Endocrinol Lett; 2006 Dec; 27(6):803-6. PubMed ID: 17187006
[TBL] [Abstract][Full Text] [Related]
20. [Hyperprolactinemia].
König MP; Kopp P
Schweiz Med Wochenschr; 1986 Mar; 116(9):265-70. PubMed ID: 3952483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
